Our prior pharmacological characterization [1] led us to predict that CRF2-R receptors are required for CRF-induced aversion, and this current report suggests that CRF-induced anxiety-like behavior may be mediated by a different CRF1-R dependent activation of dynorphin/KOR signaling. The gene discussed is OPRK1; the disease is Anxiety.